Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03589326 · OUTCOME

Overall Survival (OS)

A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia · Source last updated 2025-11-26

This outcome was registered, but no numerical results were posted in the captured record.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Up to approximately 3 to 6 years

What was measured

OS is defined as interval between the randomization and death due to any cause, censored at the last contact date when the participant was alive.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
anticipated Posting Date
2028-07
denom Units Selected
Participants
description
OS is defined as interval between the randomization and death due to any cause, censored at the last contact date when the participant was alive.
reporting Status
NOT_POSTED
time Frame
Up to approximately 3 to 6 years
title
Overall Survival (OS)
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice